Met Life Investment Management, LLC Ionis Pharmaceuticals Inc Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 9,161 shares of IONS stock, worth $626,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,161
Previous 9,144
0.19%
Holding current value
$626,612
Previous $275,000
31.27%
% of portfolio
0.0%
Previous 0.0%
Shares
43 transactions
Others Institutions Holding IONS
# of Institutions
413Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.14 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.1 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$858 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$706 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$537 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $9.71B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...